Concluding remarks

Endocannabinoid system
Endogenous cannabinoids (endocannabinoids) are an emerging class of lipid mediators isolated from brain (Devane et al., 1992) , peripheral tissues (Sugiura et al., 2002) and reproductive fluids with psychotropic, hypnotic and analgesic effects matching cannabinoids Page 2 of 17 A c c e p t e d M a n u s c r i p t (Ledent et al., 1999) . To date, at least four brain-derived compounds have been identified and designed as endocannabinoids (Devane et al., 1992; Sugiura et al., 2002; Stella et al., 1997; Hanus et al., 2001; Porter et al., 2002) : arachidonoylethanolamide, (AEA or anandamide), 2-arachidonylglycerol (2-AG), 2-arachidonyl-glyceryl ether and virodhamine. Furthermore, several additional lipid mediators, such as N-oleoylethanolamine (OEA) and N-palmitoylethanolamine (PEA), are now considered endocannabinoid-like molecules or entourage compounds being able to improve the activity of AEA and 2-AG by inhibiting their degradation (Ben-Shabat et al., 1998; Lambert and Di Marzo 1999; De Petrocellis et al., 2004) . AEA and 2-AG are the endocannabinoids whose biological activity has been better characterized Hillard et al., 2003) .
They bind to extracellular site of the G-protein coupled type-1 and type-2 cannabinoid receptors (CB1 and CB2) (Matsuda et al., 1990; Munro et al., 1993) matching some effects of D 9 -tetrahydrocannabinol (THC), the primary psycho-active component of marijuana (Howlett et al., 2002 ). These two compounds have different affinities for CB1 and CB2, being AEA more selective for the former and 2-AG equally potent and efficacious at both binding sites (Howlett et al., 2002) .
Unlike 2-AG, AEA also acts on intracellular sites of ion channels such as those of the transient receptor potential vanilloid type 1 (TRPV1 or VR1) protein (also activated by the pungent compound of hot chilli pepper, capsaicin) and the T-type calcium channels (van der Stelt et al., 2005) . The effects of AEA and 2-AG, via CB1 and CB2 receptors, depend on their concentration in the extracellular space which is controlled by: i) Ca
2+
-dependent biosynthesis occurring on demand by membrane precursors and requiring the sequential action of specific enzymes [e.g Nacyltransferase (NAT) ( Hansen et al., 2000) and N-acylphosphatidylethanol-amine (NAPE)-specific phospholipase-D (PLD) for AEA (Okamoto et al., 2004) , and phosphatidic acid phosphohydrolase or phosphoinositide-selective phospholipase C (PI-PLC) as well as sn-1-diacylglicerol lipase (DAGL) for 2-AG ; ii) cellular uptake requiring a hypothesized endocannabinoid membrane transporter (EMT) (Beltramo and Piomelli 2000) and iii) intracellular degradation requiring fatty acid amide hydrolyse (FAAH), to degrade both AEA and 2-AG, as well as monoacylglycerol lipase (MAGL), to degrade specifically 2-AG (Dinh et al., 2002; Ho et al., 2002) .
Altogether, endocannabinoids, receptors, transporter, enzymes for their synthesis and degradation constitute the "endocannabinoid system" (Beltramo et al., 1997; Hillard et al., 1997; Di Marzo et al., 1999; .
Endocannabinoid system and spermatogenesis
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It is now well established that cannabinoids/endocannabinoids influence the male reproductive function (Maccarrone et al., 2002; Brown and Dobs 2002) . Cannabinoids inhibit spermatogenesis, reduce the weight of reproductive organs, and also production, motility and viability of sperm cells (Kolodny et al., 1974) . Furthermore, they regulate testosterone production by Leydig cells both in vivo and in vitro (Dalterio et al., 1983) and cause impotency in male rat (Murphy et al., 1994) .
Endocannabinoids are synthesised by gonads. Rat testis produces AEA (Sugiura et al., 1996) .
Feasible testicular AEA sources are Sertoli and germ cells since isolated mammalian immature Sertoli cells (Maccarrone et al., 2003) and mammalian and non mammalian spermatozoa (SPZ) (Maccarrone et al., 2005; Cobellis et al., 2006) produce endocannabinoids. The presence of AEA in the testis suggests that endocannabinoids are implicated in spermatogenesis and/or steroidogenesis.
Accordingly, orthologues of CB receptors and FAAH have been evidenced in testis of the invertebrate, Ciona intestinalis (Matias et al., 2005) , CB receptors have been localized in germinal compartment cells of mammalian male gonad (Gye et al., 2005) , and CB1-knockout (CB1-KO) mice show low secretion of testicular testosterone in in vitro study (Wenger et al., 2001) . However, few data exist to establish physiology of endocannabinoids in testicular activity.
Spermatogenesis is a process highly conserved throughout vertebrate species (Perantoni et al., 2002; Cobellis et al., 2003) . Thus, committed spermatogonia (SPG) develop in spermatocytes (SPCs) and enter meiosis to produce spermatids (SPTs). These undergo a morphological transformation (spermiogenesis) into mature elongated SPT (also indicated as SPZ) which are differentially released from Sertoli cells (spermiation) depending on the species. Therefore, spermatogenesis involves mitosis, meiosis and differentiation events in spermiogenesis. These events are driven by gonadotropin and by a network of local signals whose presence is suggested by testicular morphology Cobellis et al., 2003) . In mammals, two compartments are A c c e p t e d M a n u s c r i p t vertebrate models show anatomical organizations that allow access to tissues not readily approachable in mammals. Thus, the testicular zonation in elasmobranches (Fig. 1A ) (Pratt 1988; Pierantoni and Fasano 1991) , or the compartimentalization in urodeles (Fig. 1B) (Lofts 1987; , as well as the cyclic regeneration of the interstitium, including differentiating Leydig cells, in the reptile, Podarcis s. sicula (Andò et al., 1990) , may facilitate analysis of signals promoting differentiation of testicular cells. The anuran amphibian, the frog Rana esculenta, represents a powerful tool to easily delineate the molecular signalling implicated in the control of spermatogenesis (Pierantoni et al., 2002a; Pierantoni et al,. 2002b; Cobellis et al., 2003) . Spermatogenesis occurs in cysts consisting of Sertoli cells enveloping clusters of germ cells at a synchronous stage (Fig. 1C ) (Rastogi et al., 1976) . During the annual sexual cycle new cysts monthly appear and progress throughout spermatogenesis stages depending on endocrine and local events (Pierantoni et al., 2002b) . This conveys the considerable advantage to have in each period of the year a defined and well known population of germ cysts. As a consequence, during the year, when in February-March period spermatogenesis resumes and SPG proliferate, the cystic organization of spermatogenesis progressively enriches the testis of clusters of SPC (May-June)
followed by SPT appearance (September-October) and SPZ, retained in the tubules until March, when spermiation and sperm release occur (Rastogi et al., 1976) .
Using a comparative approach, we have recently evidenced CB1 and FAAH in the testis of frogs (Cobellis et al., 2006) and rats (Cacciola G., Chioccarelli T., Mackie K., Meccariello R., Fasano S., Pierantoni R., Cobellis G., unpublished). Data confirm and/or extend previous studies carried out in mice demonstrating the presence of FAAH in isolated immature Sertoli cells (Maccarrone et al., 2003) and CB1 in Leydig (Wenger et al.2001; Gye et al., 2005) and germ cells (from spermatogonia to SPZ) (Gye et al., 2005) . In frogs (Cobellis et al., 2006) , the expression profile of CB1 and FAAH during the annual sexual cycle (Fig. 2) A c c e p t e d M a n u s c r i p t localization of CB1 and FAAH in eSPT (Fig 3) suggests the involvement of the endocannabinoid system in spermiogenesis (probably in acrosome and cellular shape configuration) and also hints that FAAH, controlling endocannabinoid levels, establishes the endocannabinoid tone needed for a right morphology of these cells. Accordingly, marijuana smokers show morphological alterations of SPZ (Hembree et al., 1978; Issidorides 1978) . Localization of CB1 in Sertoli cells, here reported, does not agree with data obtained by Maccarrone et al. (2003) . However, results can be reconciled.
In fact, it is well know that functional activity of Sertoli cells depends on the associated germ cell stages. Maccarrone used immature Sertoli cells from 4-16 dpp old mice. Since at that time only SPG and SPC are present in the testis while more mature stages of germ cells are almost absent (Bellvé et al., 1977) , it is possible to postulate that CB1 switches on in Sertoli cells later in development to support mature germ cells (from rSPT to SPZ). Accordingly, in adult rat, CB1
stained Sertoli cells appear in stages with elongating SPT (Cacciola G., Chioccarelli T., Mackie K., Meccariello R., Fasano S., Pierantoni R., Cobellis G., unpublished). The immunolocalization of CB1 in the testis during the first wave of spermatogenesis could reveal when CB1 appears in Sertoli cells. Further experiments should be carried out in this respect.
Endocannabinoid system and acquisition of sperm motility
After spermatogenesis, the mature SPT are released from Sertoli cells into the tubule lumen (spermiation) and proceed through the excurrent duct system, differentially organized according to the species (Pierantoni 1998; Birkhead 1998; Le Gac and Lair 1998; Johnson et al., 1998) . In amphibians (Fig.4A ), we observe a simple excurrent duct system with several efferent ducts, leaving testis and entering only one external duct (properly indicated as spermatic duct) which confluences in cloaca. In mammals (Fig.4B) , a more complex excurrent duct system, where sperm maturation occurs, is present; it includes: rete testis, efferent ducts, epididymus, vas deferens, ejaculatory duct and a segment of the urethra. Some of the main events of sperm maturation (i.e membrane remodelling, motility acquisition, chromatin condensation and the movement of cytoplasmic droplet from the neck to the head of mid piece) occur in the epididymus (Redman 1998 ).
Recently, it has been shown that endocannabinoids are present in amphibian cloacal fluid (Cobellis et al., 2006) and in human seminal plasma , suggesting that endocannabinoids may influence important steps controlling sperm maturation or function (Wang et al., 2006) .
Consistently, a complete endocannabinoid system has been characterized in boar SPZ. These cells produce AEA and express TRPV1, FAAH, CB2 and CB1 (Maccarrone et al., 2005) . CB1 has also been evidenced in human sperm (Rossato et al., 2005) while in frog, rat (Cobellis et al., 2006) and
A c c e p t e d M a n u s c r i p t boar (Maccarrone et al., 2005 ) SPZ, both CB1 and FAAH have been detected. Immunofluorescence demonstrates that CB1 is present in the head and tail of human (Rossato et al., 2005) , boar (Maccarrone et al., 2005) and rat SPZ (Cacciola G., Chioccarelli T., Mackie K., Meccariello R., Fasano S., Pierantoni R., Cobellis G., unpublished) . Unlike boar, where CB1 is localized in postacrosomal region, in rats the confocal analysis shows the protein near the acrosome. Altogether these findings support the observation concerning the endocanabinoid influence on acrosome reaction Maccarrone et al., 2005; Schuel et al., 2005) and sperm motility (Rossato et al. 2005; Cobellis et al., 2006) 
through CB1.
In vitro studies show that AEA inhibits motility of human (Rossato et al., 2005) and frog SPZ (Cobellis et al., 2006) . In particular, the inhibitory effect on frog SPZ is mediated by CB1 (as in humans) and is counteracted by sperm washing (Fig. 5A ) or dilution (Fig. 5B) ; furthermore, motility is counteracted by CB1 antagonist in cloacal fluid (Fig. 5C ), suggesting that endocannabinoids control the number of motile SPZ, via CB1, keeping sperm motility quiescent until their release in aquatic environment ("dilution mechanism"). Since the endocannabinoid system has been demonstrated to be highly conserved in evolution (Matias et al., 2005) , the new perspective coming from the above described data is that, besides frogs, a change of CB1 receptor activity and/or endocannabinoid levels might control sperm motility acquisition also in mammals along the epididymus from the caput to the cauda (Ricci et al., 2007) . In mammals, the mechanism of sperm motility acquisition, needed for fertilization, is a two step mechanism: 1) the former occurs in the epididymus; 2) the latter occurs in the female reproductive tract. In fact, after spermiation, immotile SPZ reach the epididymus by passive transport and here, moving from caput to cauda, acquire motility (Cobellis et al., 2005 and references there in) . The phenotype analysis of wild type (WT) and CB1-KO male mice (Ricci et al., 2007) demonstrates that endocannabinoid/CB1 signalling affects sperm motility in the epididymus. Indeed, lack of CB1
clearly increases the percentage of motile SPZ in caput which becomes comparable to that observed in the cauda. These results let to hypothesise that CB1 signalling control number of motile SPZ along the epididymus (low in caput and high in cauda) keeping quiescent sperm motility in the caput.
Concluding remarks
Male reproduction requires a network of endocrine, paracrine as well as autocrine mechanisms and comparative studies indicate that highly conserved processes are active among phylogenetically distant species.
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Data here reported suggest that the endocannabinoid system regulates male reproduction from C. intestinalis to mammals. Moreover, sperm motility acquisition mechanism seems to be conserved in both amphibians and mammals. Indeed, endocannabinoids play a central inhibitory role in either animal systems but, of course, they adapt actions depending on the environment. In amphibians, where external (aquatic) fertilization occurs, a "dilution mechanism" evolved to enhance sperm motility; in mammals, living in the terrestrial environment, a mechanism generated into epididymus and involving CB1 activity is generated to trigger sperm motility in cauda. 
Legends
